Objectives of the CRT Meeting
The May and July CRT meetings aim to discuss implementation science in cardiovascular medicine and define a vision for the promotion and adoption of evidence-based practices by integrating various ESC activities into routine healthcare provision to improve patient outcomes.
The May meeting focused on the barriers that may limit the widespread adoption of the ESC Guidelines and delved into these challenges on the local, regional, and national levels. The group discussed how data collection and educational activities can help identify gaps in implementation and how healthcare systems, socio-economic factors as well as physicians and allied health professionals may impact the adherence to guideline-indicated treatments.
The July meeting will discuss innovative mechanisms and quality of care improvement strategies aimed at addressing the ‘evidence-practice’ gap, with the ultimate goal of proposing a comprehensive implementation programme to improve patient care.
Session Recordings
Day 1 - Session 1
Day 1 - Session 2
Day 2 - Session 1
Day 2 - Session 2
Final Programme
Academic Chairpersons
- Dr. Suleman Aktaa
- Prof. Eva Prescott
- Prof. Susanna Price
- Prof. Thomas F. Lüscher (ESC President-elect and ESC Chair of the CRT)
Industry Chairpersons
- Dr Alphons Vincent/Medtronic
- Dr. Ricardo Rocha (Intellia Therapeutics)
- Dr. Tamara Krcmar (Servier International)
- Prof. Alexandra Goncalves /BMS (Industry Chair of the CRT)
Day 1: 10 July 2024 13:30–18:30 CEST
|
Time |
Session |
Speaker |
|---|---|---|
|
12:00-13:30 |
Arrival and Buffet Lunch |
|
|
13:30-13:35 |
Welcome from the CRT Chairpersons |
Alexandra Goncalves (BMS) Thomas F. Lüscher |
|
13:35 -15:30 |
SESSION 1.1 – What is implementation science and examples of programs that facilitate quality improvement Moderated by: Susanna Price and Alphons Vincent (Medtronic) |
|
|
13:35-13:45 |
Summary of the previous CRT meeting |
Eva Prescott Ricardo Rocha (Intellia Therapeutics) |
|
13:45-14:05 |
The art of implementing guidelines on lipid management | Laney Jones (Amgen) |
|
14:05-14:10 |
5 MINUTE BREAK |
|
|
14:10-14:30 |
Lessons from the European Bone Marrow transplant initiative | Tuula Rintala (EBMT) |
|
14:30-14:50 |
Accreditation of centers, the French example | Anne Chevrier Haute Autorite de Sante (via ZOOM) |
|
14:50-15:10 |
PANEL DISCUSSION | |
|
15:10-15:35 |
Coffee Break | |
| 15:35 -18:30 |
SESSION 1.2 – An ESC approach to supporting implementation science and quality of care Moderated by: Eva Prescott & Ricardo Rocha (Intellia Therapeutics) |
|
|
15:35-15:40 |
An integrated ESC quality of care programme: putting theory in action | Demonstration Video |
|
15:40-16:25 |
Operationalization of the ESC QoC Programme: from Guidelines to outcomes |
Susanna Price (Education) Chris Plummer (Exams & accreditation) Stefan James (Registries) Julie Sanders (Outcomes including PROMS) Stephan Windecker (Trials) Felix Tanner (Training) Suleman Aktaa (Quality assessment & programme implementation) |
| 16:25-17:25 |
BREAKOUT SESSIONS: Barriers and Solutions to implement an ESC Quality of Care (QoC) Programme Simulation OF THE PRACTICALITY OF THE ESC QOC PROGRAMME implementation with focusing on: |
|
|
|
Group 1: Systems: National healthcare system, institutional characteristics |
Lead: Mirko de Melis (Medtronic) Rapporteur: Thomas Rosemann |
|
|
Group 2: Finance aspects |
Lead: Stefan James Rapporteur: Maria Ripa (Novo Nordisk) |
|
|
Group 3: Physician, allied health professional, patient |
Lead: Carlos Eid (Novartis) Rapporteur: Nico Bruining |
| 17:25-17:35 |
Report from breakout session 1 |
Rapporteur: Thomas Rosemann |
| 17:35-17:45 |
Report from breakout session 2 |
Rapporteur: Maria Ripa (Novo Nordisk) |
| 17:45-17:55 |
Report from breakout session 3 |
Rapporteur: Nico Bruining |
| 17:55-18:25 |
PANEL DISCUSSION |
|
| 18:25-18:30 | Wrap-up and summary day 1 – Outlook to day 2 |
Alexandra Goncalves (BMS) Thomas F. Lüscher |
|
END OF DAY 1 |
||
|
19:30 |
APERITIF + DINNER |
|
Day 2: 11 July 2024 08:20–12:00 CEST
|
Time |
Session |
Speaker |
|---|---|---|
|
08:00-08:10 |
Summary of day 1 |
|
|
08:10 - 09:50 |
SESSION 2.1: Drivers than can support quality improvement Moderated by: Eva Prescott & Alexandra Goncalves (BMS) |
|
|
08:10-08:30 |
Financial incentives for quality improvement interventions in public healthcare systems; the NICE strategy |
|
|
08:30-08:50 |
Reimbursement for quality improvement interventions in insurance-based healthcare systems (the German example) | |
|
08:50-09:35 |
BREAKOUT SESSIONS: Accreditation as a recognition and incentive for centers | |
|
Group 4: Incentives for center to participate in a quality-of-care programme |
Lead: Harriett Van Spall Rapporteur: Alphons Vincent (Medtronic) |
|
|
Group 5: Sustainability of accreditation overtime from the ESC & center perspectives |
Lead: Ricardo Rocca (Intellia Therapeutics) Rapporteur: Xavier Rosselló |
|
|
09:35-09:40 |
Report from breakout session 4 |
Rapporteur: Alphons Vincent (Medtronic) |
|
09:40-09:50 |
Report from breakout session 5 |
Rapporteur: Xavier Rosselló |
|
09:50-10:20 |
Coffee Break |
|
|
10:20 - 12:10 |
SESSION 2.2: A focus on digital solutions and tools to support implementation science and quality of care Moderated by: Thomas F. Lüscher & Tamara Krcmar (Servier International) |
|
|
10:20-10:50 |
Digital health to improve guideline-based management Decision support tools in clinical practice: from theory to concrete application |
Nico Bruinning Nandor Nagy (GE) |
|
10:50-11:10 |
Large language models for decision support: A real-world example |
|
|
11:10-11:55 |
PANEL DISCUSSION |
|
|
11:55-12:00 |
Wrap-up, conclusions, next steps for publication |
Alexandra Goncalves (BMS) |
|
END OF DAY 2 |
||
|
12:00 |
Buffet Lunch and Departures |
|
Biographies
- Prof. Thomas F. LÜSCHER, UK
- Prof. Alexandra GONCALVES, BMS
- Dr. Suleman AKTAA, UK
- Prof. Folkert ASSELBERGS, Netherlands
- Prof. Nico BRUINING, Netherlands
- Ms. Anne CHEVRIER, France
- Dr. Mirko DE MELIS, Medtronic
- Dr. Carlos EID, Novartis AG
- Prof. Gerhard HINDRICKS, Germany
- Prof. Stefan JAMES, Sweden
- Dr. Laney JONES, Amgen
- Ms. Tamara KRCMAR, Servier Affaires Internationales
- Mr. Mark MINCHIN, National Institute for Health and Care Excellence
- Dr. Nandor NAGY, GE Healthcare
- Dr. Chris PLUMMER, UK
- Prof. Eva PRESCOTT, Denmark
- Prof. Susanna PRICE, UK
- Ms. Tuula RINTALA, EBMT
- Dr. Maria Sejersten RIPA, Novo Nordisk
- Dr. Ricardo ROCHA, Intellia Therapeutics
- Prof. Thomas ROSEMANN, Switzerland
- Associate Prof. Xavier ROSSELLÓ, Spain
- Prof. Julie SANDERS, UK
- Mr. Richard STEPHENS, UK
- Prof. Felix C. TANNER, Switzerland
- Dr. Harriette VAN SPALL, Canada
- Dr. Alphons VINCENT, Medtronic
- Prof. Stephan WINDECKER, Switzerland
Our mission: To reduce the burden of cardiovascular disease.